Pharmaceutical Softgel Capsule Market Size, Share and Trends Analysis Report, By Product Type (Gelatin Softgel Capsule and Non-Gelatin Softgel Capsule), By Application (Anti-inflammatory Drugs, Antibiotic Drugs, Health Supplements, Cardiovascular Drugs, and Others), By End-User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), Forecast (2022-2028)

The global pharmaceutical softgel capsule market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). In 2019, according to the American Heart Association, approximately 1,055,000 people suffer from heart disease in the US.The rise in cardiovascular diseases has played a key role in increasing the demand for the pharmaceutical softgel capsule. Therefore, a significant increase in the prevalence of cardiovascular problems is expected to drive the growth of the global pharmaceutical softgel capsule market. In addition increase in focus on bringing in a wider variety of gelatin soft gel capsules to meet the growing demand for usage as vitamin supplements have taken care of the industry growth.

Moreover, leading pharmaceutical companies are focusing on the development of a drug for cardiovascular treatment.Therefore, the market growth is driven by the strong focus of the pharmaceutical companies and research organizations on the R&D of drugs for cardiovascular disease treatment, which have taken care of the pharmaceutical softgel market growth.

In October 2020, Catalent, Inc., a subsidiary of Lonza Company, increased its gelatin capsule production capacity by investing $ 93 million in its pill and healthcare (CHI) category and the investment has led the company to increase its production capacity of capsules within Capsugel’s CHI portfolio by producing 30 billion pills a year.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By Application
  • By End-Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Sirio Pharma Company Ltd, CaptekSoftgel International Inc, Elnova Pharma, Fuji Capsule Co., Ltd., EuroCaps Ltd, and Guangdong Yichao Biological Co., Ltdamong others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pharmaceutical Softgel Capsule Market Report by Segment

By Product Type

• Gelatin Softgel Capsule
• Non-gelatin Softgel Capsule

By Application

• Anti-inflammatory Drugs
• Antibiotic Drugs, Health Supplements
• Cardiovascular Drugs
• Others

By End-Users

• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Others

Global Pharmaceutical Softgel Capsule Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa